Literature DB >> 8227301

Time course study of the isometric contractile properties of mdx mouse striated muscles.

C Pastoret1, A Sebille.   

Abstract

The isometric twitch and tetanic contractions of three hindlimb muscles (soleus, plantaris, extensor digitorum longus) were recorded in situ in groups of mdx and C57BL/10 control mice at young, adult and old ages (3, 4, 6, 8, 13, 26, 39 and 52 weeks). Based on a two-way analysis of variance (age/phenotype) the mdx phenotype did not modify the absolute tension but was associated with a significant decrease in the tetanic tension normalized to muscle weight in all the muscles which became heavier. These results suggest that the contractile material in mdx is not so powerful as in controls. Moreover, significantly faster time to peak and half-relaxation time were observed in mdx soleus and plantaris. Comparison between these contraction characteristics and those of other experimental models suggests that the high percentage of regenerated fibres in mdx muscles could play a role in modifying contractile properties.

Entities:  

Mesh:

Year:  1993        PMID: 8227301     DOI: 10.1007/bf00121294

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  45 in total

1.  THE RATE OF TENSION DEVELOPMENT IN ISOMETRIC TETANIC CONTRACTIONS OF MAMMALIAN FAST AND SLOW SKELETAL MUSCLE.

Authors:  A J BULLER; D M LEWIS
Journal:  J Physiol       Date:  1965-02       Impact factor: 5.182

Review 2.  Invited review: myoblast transfer: a possible therapy for inherited myopathies?

Authors:  T A Partridge
Journal:  Muscle Nerve       Date:  1991-03       Impact factor: 3.217

Review 3.  Dystrophin abnormalities in Duchenne/Becker muscular dystrophy.

Authors:  E P Hoffman; L M Kunkel
Journal:  Neuron       Date:  1989-01       Impact factor: 17.173

Review 4.  Dynamic properties of mammalian skeletal muscles.

Authors:  R I Close
Journal:  Physiol Rev       Date:  1972-01       Impact factor: 37.312

5.  Histopathological changes in Duchenne muscular dystrophy.

Authors:  C D Bell; P E Conen
Journal:  J Neurol Sci       Date:  1968 Nov-Dec       Impact factor: 3.181

6.  Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.

Authors:  E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

7.  Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

Authors:  J W Carnwath; D M Shotton
Journal:  J Neurol Sci       Date:  1987-08       Impact factor: 3.181

8.  Muscle development in mdx mutant mice.

Authors:  J Dangain; G Vrbova
Journal:  Muscle Nerve       Date:  1984 Nov-Dec       Impact factor: 3.217

9.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

10.  Twitch and tetanus in mdx mouse muscle.

Authors:  J G Quinlan; S R Johnson; M K McKee; S P Lyden
Journal:  Muscle Nerve       Date:  1992-07       Impact factor: 3.217

View more
  10 in total

1.  Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.

Authors:  G S Lynch; R T Hinkle; J S Chamberlain; S V Brooks; J A Faulkner
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

2.  Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.

Authors:  Mingju Liu; Yongping Yue; Scott Q Harper; Robert W Grange; Jeffrey S Chamberlain; Dongsheng Duan
Journal:  Mol Ther       Date:  2005-02       Impact factor: 11.454

3.  The capacity of mdx mouse diaphragm muscle to do oscillatory work.

Authors:  E D Stevens; J A Faulkner
Journal:  J Physiol       Date:  2000-02-01       Impact factor: 5.182

4.  Mdx myotubes have normal excitability but show reduced contraction-relaxation dynamics.

Authors:  V Nicolas-Metral; E Raddatz; P Kucera; U T Ruegg
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

5.  Fibres of intermediate type 1C and 2C are found continuously in mdx soleus muscle up to 52 weeks.

Authors:  C Pastoret; A Sebille
Journal:  Histochemistry       Date:  1993-10

6.  Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice.

Authors:  Warren C McClure; Rick E Rabon; Hirofumi Ogawa; Brian S Tseng
Journal:  Neuromuscul Disord       Date:  2007-06-27       Impact factor: 4.296

7.  A reporter mouse for optical imaging of inflammation in mdx muscles.

Authors:  Leonel Martinez; Natalia V Ermolova; Tomo-O Ishikawa; David B Stout; Harvey R Herschman; Melissa J Spencer
Journal:  Skelet Muscle       Date:  2015-04-30       Impact factor: 4.912

8.  Effects of the selective inhibition of proteasome caspase-like activity by CLi a derivative of nor-cerpegin in dystrophic mdx mice.

Authors:  Yeranuhi Hovhannisyan; Gagik Melikyan; Nathalie Mougenot; Jacqueline Gao-Li; Bertrand Friguet; Denise Paulin; Zhenlin Li; Arnaud Ferry; Onnik Agbulut
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

9.  Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches.

Authors:  Virginie Mariot; Romain Joubert; Christophe Hourdé; Léonard Féasson; Michael Hanna; Francesco Muntoni; Thierry Maisonobe; Laurent Servais; Caroline Bogni; Rozen Le Panse; Olivier Benvensite; Tanya Stojkovic; Pedro M Machado; Thomas Voit; Ana Buj-Bello; Julie Dumonceaux
Journal:  Nat Commun       Date:  2017-11-30       Impact factor: 14.919

10.  Lifespan Analysis of Dystrophic mdx Fast-Twitch Muscle Morphology and Its Impact on Contractile Function.

Authors:  Leonit Kiriaev; Sindy Kueh; John W Morley; Kathryn N North; Peter J Houweling; Stewart I Head
Journal:  Front Physiol       Date:  2021-12-07       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.